John Overdeck’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,600
Closed -$329K 4191
2021
Q4
$329K Buy
+3,600
New +$386K ﹤0.01% 3579
2021
Q3
Sell
-8,300
Closed -$1.27M 4672
2021
Q2
$1.27M Sell
8,300
-3,400
-29% -$448K ﹤0.01% 2273
2021
Q1
$1.23M Buy
11,700
+5,700
+95% +$571K ﹤0.01% 2117
2020
Q4
$475K Buy
+6,000
New +$439K ﹤0.01% 2552
2020
Q2
Sell
-6,800
Closed -$219K 3490
2020
Q1
$219K Sell
6,800
-1,000
-13% -$33.7K ﹤0.01% 2592
2019
Q4
$274K Buy
+7,800
New +$257K ﹤0.01% 3251

Other funds holding STAA

John Overdeck's STAA Position: Q2 2026 in Review

John Overdeck reduced its STAAR Surgical (STAA) stake by 80% in Q2 2026, selling an estimated $12.5M and leaving 110,288 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2571.

John Overdeck first reported a position in STAA in Q2 2013 and has held it in 37 quarters since. The position peaked at $17.2M in Q2 2023. 199 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • John Overdeck held 110,288 shares of STAAR Surgical worth $3.16M as of Q2 2026.
  • John Overdeck sold 449,298 STAAR Surgical shares in Q2 2026, an estimated $12.5M.
  • STAAR Surgical made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2571 holding.
  • John Overdeck first reported a position in STAAR Surgical in Q2 2013 and has held it in 37 quarters since.
  • John Overdeck's STAAR Surgical position peaked at $17.2M in Q2 2023.
  • 199 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.